South Korea plans US$450 billion semiconductor spend
May 17, 2021 // By Peter Clarke, eeNews Analog
South Korea has a plan for the country to spend $450 billion on logic chipmaking and R&D up to 2030, according to Bloomberg.
It is not yet clear how big the subsidy element will be but the funds will comprise a mix of government support packages, tax incentives, and corportate investment pledges.
South Korea, China and the US all see semiconductor as strategic weapons in wealth generation and global security but notably the US government 'war' chest is being benchmarked at $50 billion. European politicians also see leading-edge chip manufacturing as strategic but are struggling to re-invigorate leading-edge chip in Europe.
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |
Related News
- Global Semiconductor Industry Plans to Invest $400 Billion in 300mm Fab Equipment Over Next Three Years, SEMI Reports
- TSMC Arizona and U.S. Department of Commerce Announce up to US$6.6 Billion in Proposed CHIPS Act Direct Funding, the Company Plans Third Leading-Edge Fab in Phoenix
- China's Unigroup plans to spend $60 billion, says report
- $55.9 Billion Semiconductor Equipment Forecast - New Record with Korea at Top
- SEMI Reports Second Quarter 2015 Worldwide Semiconductor Equipment Figures; Billings US$9.4 Billion
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design